9-137813540-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024757.5(EHMT1):​c.3180+10G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00324 in 1,613,442 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0033 ( 47 hom. )

Consequence

EHMT1
NM_024757.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.639

Publications

1 publications found
Variant links:
Genes affected
EHMT1 (HGNC:24650): (euchromatic histone lysine methyltransferase 1) The protein encoded by this gene is a histone methyltransferase that methylates the lysine-9 position of histone H3. This action marks the genomic region packaged with these methylated histones for transcriptional repression. This protein may be involved in the silencing of MYC- and E2F-responsive genes and therefore could play a role in the G0/G1 cell cycle transition. Defects in this gene are a cause of chromosome 9q subtelomeric deletion syndrome (9q-syndrome, also known as Kleefstra syndrome). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]
EHMT1 Gene-Disease associations (from GenCC):
  • Kleefstra syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Kleefstra syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-137813540-G-T is Benign according to our data. Variant chr9-137813540-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00272 (414/152238) while in subpopulation SAS AF = 0.0199 (96/4814). AF 95% confidence interval is 0.0167. There are 3 homozygotes in GnomAd4. There are 233 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 414 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024757.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EHMT1
NM_024757.5
MANE Select
c.3180+10G>T
intron
N/ANP_079033.4
EHMT1
NM_001354263.2
c.3159+10G>T
intron
N/ANP_001341192.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EHMT1
ENST00000460843.6
TSL:5 MANE Select
c.3180+10G>T
intron
N/AENSP00000417980.1
EHMT1
ENST00000637161.1
TSL:5
c.3087+10G>T
intron
N/AENSP00000490328.1
EHMT1
ENST00000462942.3
TSL:2
n.2037+10G>T
intron
N/AENSP00000436107.1

Frequencies

GnomAD3 genomes
AF:
0.00273
AC:
415
AN:
152120
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0199
Gnomad FIN
AF:
0.00698
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00232
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00484
AC:
1206
AN:
249278
AF XY:
0.00570
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.000551
Gnomad ASJ exome
AF:
0.0202
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00621
Gnomad NFE exome
AF:
0.00255
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00329
AC:
4813
AN:
1461204
Hom.:
47
Cov.:
33
AF XY:
0.00378
AC XY:
2749
AN XY:
726850
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000559
AC:
25
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.0190
AC:
497
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.0199
AC:
1711
AN:
86186
European-Finnish (FIN)
AF:
0.00594
AC:
314
AN:
52906
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5768
European-Non Finnish (NFE)
AF:
0.00182
AC:
2020
AN:
1111952
Other (OTH)
AF:
0.00361
AC:
218
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
307
615
922
1230
1537
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00272
AC:
414
AN:
152238
Hom.:
3
Cov.:
33
AF XY:
0.00313
AC XY:
233
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41540
American (AMR)
AF:
0.000327
AC:
5
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
65
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.0199
AC:
96
AN:
4814
European-Finnish (FIN)
AF:
0.00698
AC:
74
AN:
10596
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00232
AC:
158
AN:
68018
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00406
Hom.:
0
Bravo
AF:
0.00148

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 26, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Oct 21, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Kleefstra syndrome 1 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.20
DANN
Benign
0.23
PhyloP100
0.64
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113676865; hg19: chr9-140707992; API